⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Macrogen Japan Corp. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Macrogen Japan Corp.
↗Kyoto, Japan
Macrogen Japan Corp. is the Japanese subsidiary of the South Korean biotechnology company Macrogen, Inc. The company specializes in providing high-quality genomic services, including Sanger sequencing, next-generation sequencing (NGS), oligonucleotide synthesis, and bioinformatics analysis to academic institutions, research centers, and pharmaceutical companies.
As a key player in the Japanese genomics market, Macrogen Japan leverages the global infrastructure of its parent company to offer precision medicine solutions and clinical genetic testing. The company is recognized for its technical expertise and rapid turnaround times, supporting a wide range of research activities from basic molecular biology to clinical diagnostics.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Genomics and Sequencing Services
SIZE & FINANCIALS
Employees:51-200
Founded:2007
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Genomics, Bioinformatics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Macrogen, Inc. (South Korea)
Key Partnerships:Illumina (Sequencing technology), Pacific Biosciences (HiFi sequencing), Oxford Nanopore Technologies (Certified service provider)
COMPETITION
Position:Niche Player
Competitors:Eurofins Genomics, Novogene, BGI Group, Takara Bio, GenScript
LEADERSHIP
Key Executives:
Sang-Wan Kim - Representative
LINKS
Website:macrogen-japan.co.jp
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Macrogen Japan Corp.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.